Mandolin raises $40M to automate access to life-saving medicines
Mandolin, a company focused on streamlining access to specialty medications, has successfully raised $40 million in a funding round. The investment aims to enhance the company's innovative platform that simplifies the complex paperwork often associated with obtaining specialty drugs.
Background
Specialty drugs are typically more expensive and require prior authorization from insurance companies, creating barriers for patients who need these life-saving medications. Mandolin’s technology is designed to automate this process, making it easier for both healthcare providers and patients to navigate the system.
Impact of the Funding
The new funds will be used to:
- Expand the team
- Enhance technology infrastructure
- Increase outreach to healthcare providers and patients
According to Mandolin's CEO, this funding will significantly accelerate their efforts to reduce the time it takes for patients to access the medications they need.